- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Martha Gaines: Turning Experience as Cancer Survivor into Patient Advocacy
Martha Gaines, MD, JD, LLM, founder and director of The Center for Patient Partnerships, clinical professor of law, University of Wisconsin Law School, explains how she turned her experience as a cancer survivor into a model for consumer-centered patient advocacy.
Martha Gaines, MD, JD, LLM, founder and director of The Center for Patient Partnerships, clinical professor of law, University of Wisconsin Law School, explains how she turned her experience as a cancer survivor into a model for consumer-centered patient advocacy.
Transcript
How did you transform your experience as a cancer survivor into a model for consumer-centered patient advocacy?
I was sort of in partnership with my oncologist, actually, who called me one day after I had been treated and said, “We got this lady, and she’s kind of down. Can you come talk to her?” So, I went and talked to her and while I was talking to her in the hospital, she said, “Hey I have this note from my insurance company that says they’re only willing to pay for 3 nights in the hospital even though my doctor wants me to stay for 5. Can you help with that?”
I’m a lawyer by training, so I said, “give me that,” and off I went. From that experience, I did more and more of that, and then I realized this would be an extraordinary experience for students — med students, nursing, social work, pharmacy, law – anybody who has an interest in the future of healthcare. So, I brought students together from those divisions inside the Center for Patient Partnerships, and we do advocacy work for people with life threatening and serious chronic illnesses.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
In VERIFY, Rusfertide Spares Most Patients With PV a Phlebotomy for 32 Weeks, Improves QOL
June 3rd 2025Adding rusfertide to standard of care more than doubled the share of patients with polycythemia vera (PV) who did not meet criteria for a phlebotomy, according to data from the VERIFY trial.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Depth of Responses, PFS in Transplant-Ineligible Patients Match Overall Findings in CEPHEUS
June 2nd 2025Quadruplet therapy is now the accepted standard for patients newly diagnosed with myeloma who are ineligible for transplant; there is debate whether all newly diagnosed patients should have this regimen.
Read More
Trastuzumab Deruxtecan Plus Pertuzumab Improves PFS vs Standard Care in HER2+ Breast Cancer
June 2nd 2025Trastuzumab deruxtecan plus pertuzumab demonstrated statistically and clinically significant improvement in progression-free survival (PFS) in HER2-positive breast cancer, potentially representing a new standard of care.
Read More
